secwatch / observer
8-K filed May 7, 2026, 7:59 PM ET ticker RMTI CIK 0001041024
earnings confidence high sentiment neutral materiality 0.60

Rockwell Medical Q1 net sales $17.3M (-8% YoY); guides FY26 gross margin 18-22%

ROCKWELL MEDICAL, INC.

2026-Q1 EPS reported -$0.04 revenue$17,336,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ROCKWELL MEDICAL, INC. reported fiscal year 2026 results: revenue $70.0M to $75.0M.

Period
fiscal year 2026
Revenue
$70.0M to $75.0M
Result
guidance update
Exact text from the filing
Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual Guidance Net Sales $70.0M to $75.0M Gross Margin 18% to 22% Adjusted EBITDA $1.0M to $2.0M Operating Cash Flow Positive
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ROCKWELL MEDICAL, INC. reported the three months ended March 31, 2026 results: revenue $17.3 million, net income $1.6 million, EPS $(0.04).

Period
the three months ended March 31, 2026
Revenue
$17.3 million
Net income
$1.6 million
EPS
$(0.04)
Result
reported results
Exact text from the filing
reference in such a filing. --- EX-99.1 (EX-99.1) --- Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability • Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026. • Announces operational changes that are expected to generate more than $3 million in
View on SEC.gov

Browse all earnings releases →

ROCKWELL MEDICAL, INC. filing history →

Source: SEC EDGAR
accession 0001628280-26-031629
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.